Clinical Trials Directory

Trials / Unknown

UnknownNCT04351945

Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors

A Study of Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Semmelweis University Heart and Vascular Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to assess the impact of endocrine changes and their correction on survival and organ function in heart and lung transplant recipients. This study also features an investigation of the hormone levels and hormonal replacement therapy of the donors to study its role in the function of the transplanted hearts and lungs. Thyroid hormones (TSH, thyroxine, tri-iodothyronine), cortisol and the antidiuretic hormone will be studied. The former two hormone levels will be defined in the recipients just before transplantation and three days later. In the case of the donors all three hormones will be recorded at the time of the explantation. The investigators would like to record the hormonal replacement therapy in all our patients as well to see it's effect on survival and on the transplanted organ function. After the transplantation during the hospital stays all the important hemodynamic parameters, laboratory parameters, the result of the medical imagings, the medication, the length of ICU and hospital stay and the complications were recorded. Recipients will be followed for five years. Organ function will be assessed every three month for a year, after than every six month for further four years. Investigator would like to record the result of the cardiac echocardiography, spirometries, imaging, and complications. Our purpose is to compare these results against the endocrine disorders and the replacement therapy.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood testHormone levels will be measured just before transplantation, and three day after the transplantation. In case of the donors hormone levels will be defined during the explantation.

Timeline

Start date
2020-05-20
Primary completion
2022-05-15
Completion
2022-07-01
First posted
2020-04-17
Last updated
2022-01-24

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT04351945. Inclusion in this directory is not an endorsement.